Trial · NCT04649151
Results by group143
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 143
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1A: mRNA-1273 100 μg | Grade 1 | 586 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1A: Placebo | Grade 1 | 585 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1C-1: mRNA-1273 50 µg BD | Grade 1 | 627 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1C-2: mRNA-1273 50 μg BD | Grade 1 | 42 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 2: mRNA-1273 50 μg First Injection | Grade 1 | 25 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 2: mRNA-1273 50 μg Second Injection | Grade 1 | 18 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 2: mRNA-1273 50 μg BD | Grade 1 | 7 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 3: mRNA-1273.222 50 μg 1 Dose | Grade 1 | 145 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1A: mRNA-1273 100 μg | Grade 2 | 1250 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1A: Placebo | Grade 2 | 293 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1C-1: mRNA-1273 50 µg BD | Grade 2 | 501 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1C-2: mRNA-1273 50 μg BD | Grade 2 | 48 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 2: mRNA-1273 50 μg First Injection | Grade 2 | 16 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 2: mRNA-1273 50 μg Second Injection | Grade 2 | 9 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 2: mRNA-1273 50 μg BD | Grade 2 | 0 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 3: mRNA-1273.222 50 μg 1 Dose | Grade 2 | 62 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1A: mRNA-1273 100 μg | Grade 3 | 627 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1A: Placebo | Grade 3 | 59 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1C-1: mRNA-1273 50 µg BD | Grade 3 | 150 | Participants | |
| Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) | Part 1C-2: mRNA-1273 50 μg BD | Grade 3 | 9 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04649151/results